Pramlintide: an agent for glycemic control plus weight control?

Diabetes Technol Ther. 2002;4(1):63-5. doi: 10.1089/15209150252924102.
No abstract available

Publication types

  • Comment

MeSH terms

  • Amyloid / adverse effects
  • Amyloid / therapeutic use*
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism*
  • Body Mass Index
  • Body Weight / drug effects*
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Humans
  • Islet Amyloid Polypeptide
  • Reproducibility of Results

Substances

  • Amyloid
  • Blood Glucose
  • Islet Amyloid Polypeptide
  • pramlintide